LAS VEGAS, Oct. 20, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- Grey Cloak Tech Inc. (OTC: GRCK) (soon to be Healthy Extracts Inc. pending a corporate name change), a company engaged in proprietary development of natural plant-based formulations as well as sales and distribution of clinically proven cardiovascular and neuro products, is pleased to announce an independent corporate analysis prepared by David L. Lavigne, senior analyst and managing partner at Trickle Research specializing in independent microcap research.

“We are continually striving to build credibility and confidence within the investment community,” said Duke Pitts, president and CEO of Grey Cloak Tech, soon to be Healthy Extracts Inc., “and having an independent analysis research report provides positive insight, with a projected $0.17 price target in 12 to 24 months.”

In the month of October, the company has filed for its name change to Healthy Extracts Inc., a ticker symbol change, and an upgrade to the OTCQB Venture Market, and the company has provided several press releases showing its commitment to building a strong foundation and indicating why investors should be excited about Grey Cloak Tech’s short- and long-term future. Grey Cloak Tech is committed to increasing sales and distribution while developing and formulating the absolute best heart and brain health nutraceutical products in the market.

About Grey Cloak Tech Inc. 

Grey Cloak Tech Inc. (OTC: GRCK), soon to be Healthy Extracts Inc. pending a corporate name change, through its two subsidiaries, BergaMet NA and Ultimate Brain Nutrients (“UBN”), is engaged in proprietary research and development of natural plant-based formulations, as well as the sale and distribution of natural ingredient cardiovascular and neuro products. For more information, visit the company’s websites:
www.GreyCloakTech.comwww.HealthyExtractsInc.com, www.BergametNA.com, www.UBNutrients.com

The OTCQB Venture Market, operated by OTC Markets Group Inc., is a premier market for entrepreneurial and development-stage U.S. and international companies that are committed to providing investors with high-quality trading and improved market visibility to enhance trading liquidity. To be eligible, companies must be current in their financial reporting, pass a minimum bid price test and other initial listing requirements, and undergo an annual company verification and management certification process.

Forward-Looking Statements and Safe Harbor Notice

All statements other than statements of historical facts included in this press release are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as "projected," "expect," "possibility" and "anticipate." The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the Company's Annual Report on Form 10-K filed with the SEC on April 1, 2020, and future periodic reports filed with the SEC. All of the Company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.

The Company cautions that statements and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only as of the date hereof. The Company and its management undertake no obligation to revise these statements following the date of this news release.

Grey Cloak Tech Inc.:
Info@GreyCloakTech.com
www.greycloak.comwww.HealthyExtractsInc.com

Corporate Communications:
InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com